Rarity Bioscience
Developer of assays for diagnostics of cancer
📍 Uppsala, Sweden · Clinical Genomics
Funding snapshot
Last roundSeries A
Amount$7M
Date18 June 2024
About
Developer of assays for diagnostics of cancer. It offers molecular amplification technology to detect DNA sequence variants that are used to track cancer mutations in patients' tissue or liquid biopsies.
Latest news
No articles yet.
Similar startups
NovaHealth AI
Clinical documentation copilot for ambulatory care networks in the US.
Statiq
Manufacturer of electric vehicle charging hardware and operator of networks
Spyne.ai
Platform offering AI-powered imaging for vehicle photography
Immuneel
Developer of T-cell therapies for the treatment of cancer